Assessment of Clinical Factors that Predict Response to Nabilone for Agitation in Alzheimer's Disease: A Post Hoc Analysis of a Randomized Control Trial
AD patients with pain, apathy and appetite changes, and with less cognitive impairment and not on ChEIs, were most likely to benefit from nabilone. If replicated with phase 3 data, these predictors may assist in guiding clinicians on who is likely to benefit from nabilone when managing agitation.
Authors
- Yejin Kang (ORCID: https://orcid.org/0000-0002-3436-1846)
- Alex Kiss
- Hui Jue Wang
- Krista L. Lanctôt (ORCID: https://orcid.org/0000-0001-7024-6637)
- Giovanni Marotta
- Oriel J. Feldman (ORCID: https://orcid.org/0000-0002-5201-133X)
- Myuri Ruthirakuhan
- Sandra E. Black
- Damien Gallagher
- Nathan Herrmann
Institutions
- Sunnybrook Health Science Centre (CA)
- University of Toronto (CA)
- Health Sciences Centre (CA)
- Ontario Brain Institute (CA)
- Sunnybrook Hospital (CA)
- Sunnybrook Research Institute
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70857_103582
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00